BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Passaes C, Millet A, Madelain V, Monceaux V, David A, Versmisse P, Sylla N, Gostick E, Llewellyn-Lacey S, Price DA, Blancher A, Dereuddre-Bosquet N, Desjardins D, Pancino G, Le Grand R, Lambotte O, Müller-Trutwin M, Rouzioux C, Guedj J, Avettand-Fenoel V, Vaslin B, Sáez-Cirión A. Optimal Maturation of the SIV-Specific CD8+ T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC Study. Cell Rep 2020;32:108174. [PMID: 32966788 DOI: 10.1016/j.celrep.2020.108174] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Sugawara S, Reeves RK, Jost S. Learning to Be Elite: Lessons From HIV-1 Controllers and Animal Models on Trained Innate Immunity and Virus Suppression. Front Immunol 2022;13:858383. [PMID: 35572502 DOI: 10.3389/fimmu.2022.858383] [Reference Citation Analysis]
2 Rahman AN, Liu J, Mujib S, Kidane S, Ali A, Szep S, Han C, Bonner P, Parsons M, Benko E, Kovacs C, Yue FY, Ostrowski M. Elevated glycolysis imparts functional ability to CD8+ T cells in HIV infection. Life Sci Alliance 2021;4:e202101081. [PMID: 34548381 DOI: 10.26508/lsa.202101081] [Reference Citation Analysis]
3 Deeks SG, Archin N, Cannon P, Collins S, Jones RB, de Jong MAWP, Lambotte O, Lamplough R, Ndung'u T, Sugarman J, Tiemessen CT, Vandekerckhove L, Lewin SR; International AIDS Society (IAS) Global Scientific Strategy working group. Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021. Nat Med 2021;27:2085-98. [PMID: 34848888 DOI: 10.1038/s41591-021-01590-5] [Reference Citation Analysis]
4 Rutishauser RL, Trautmann L. CD8+ T-cell responses in HIV controllers: potential implications for novel HIV remission strategies. Curr Opin HIV AIDS 2022. [PMID: 35777930 DOI: 10.1097/COH.0000000000000748] [Reference Citation Analysis]